Mega Lifesciences Public Company Limited

Thailand Stock Exchange MEGA.BK

Mega Lifesciences Public Company Limited Price to Sales Ratio (P/S) on January 14, 2025: 1.85

Mega Lifesciences Public Company Limited Price to Sales Ratio (P/S) is 1.85 on January 14, 2025, a -19.08% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Mega Lifesciences Public Company Limited 52-week high Price to Sales Ratio (P/S) is 2.36 on January 25, 2024, which is 27.51% above the current Price to Sales Ratio (P/S).
  • Mega Lifesciences Public Company Limited 52-week low Price to Sales Ratio (P/S) is 1.79 on December 24, 2024, which is -2.86% below the current Price to Sales Ratio (P/S).
  • Mega Lifesciences Public Company Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 2.10.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
Thailand Stock Exchange: MEGA.BK

Mega Lifesciences Public Company Limited

CEO Mr. Vivek Dhawan
IPO Date Nov. 19, 2013
Location Thailand
Headquarters 909, Ample Tower
Employees 900
Sector Health Care
Industries
Description

Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures, markets, and sells health food supplements, prescription pharmaceutical products, over-the-counter (OTC) products, herbal products, vitamins, and fast moving consumer goods. The company operates through Brands, Distribution, and Original Equipment Manufacture segments. It provides various complementary medicines for bone and joint, children, diabetic, heart, herbal, liver and digestive, skin, slimming, and well-being care, as well as men's and women's care products and sports supplements; gastrointestinal and pain care OTC medicines; and prescription medicines in the areas of iron supplement, anticoagulant, diabetology, cardiology, dermatology, gastroenterology, neurology, pain, osteoporosis, respiratory, urology, oncology, and nephrology. The company also offers logistical and marketing services for the sale of goods manufactured by third parties. In addition, the company engages in the operation of wellness center; and software design, development, and other services business. It operates in the Asia Pacific, the Middle East, Africa, and the Commonwealth of Independent States. The company was incorporated in 1982 and is headquartered in Bangkok, Thailand. Mega Lifesciences Public Company Limited is a subsidiary of Unistretch Limited.

Similar companies

MINT.BK

Minor International Public Company Limited

USD 0.68

-1.23%

BCH.BK

Bangkok Chain Hospital Public Company Limited

USD 0.41

-2.71%

BDMS.BK

Bangkok Dusit Medical Services Public Company Limited

USD 0.67

-2.06%

HMPRO.BK

Home Product Center Public Company Limited

USD 0.24

-3.94%

StockViz Staff

January 15, 2025

Any question? Send us an email